Ultra-rapid outpatient treatment of patients with severe aortic stenosis presenting with acute valve syndrome: evaluation of a novel pathway for urgent TAVI.
An ultra-rapid outpatient pathway for selected acute valve syndrome patients undergoing TAVI can successfully reduce total length of hospital stay without a significant increase in death or acute decompensation prior to TAVI.
Key Findings
Results
Outpatient TAVI pathway significantly reduced total length of hospital stay compared to inpatient management.
Median total length of hospital stay was 12 days (IQR 7–17) for outpatients versus 20 days (IQR 15–32) for inpatients (p<0.0001).
The reduction in hospital stay saved an estimated 210 hospital bed-days.
The study included consecutive AVS patients over 6 months pre-pathway and 12 months post-pathway implementation at a single centre.
Results
Approximately half of AVS patients evaluated for the outpatient pathway met criteria for outpatient treatment.
183 total patients were included in the study.
105 patients were evaluated for outpatient treatment after pathway introduction.
58 of 105 (55.2%) met criteria for outpatient treatment; the remaining 47/105 (44.8%) were managed as inpatients.
There was no significant difference in demographic or echocardiographic characteristics between the outpatient and inpatient management groups.
Results
There was no significant difference in time from referral to TAVI between outpatient and inpatient pathways.
Median time from referral to TAVI was 15 days (IQR 13–20) for outpatients versus 14 days (IQR 10–18) for inpatients (p=0.22).
This indicates that reducing hospital stay did not delay definitive treatment.
Results
The outpatient pathway did not result in a significant increase in death or acute decompensation prior to TAVI.
The primary safety endpoint was death or acute decompensation prior to TAVI.
Incidence of the safety endpoint was 6.9% in the outpatient group versus 6.4% in the inpatient group (HR 0.97, 95% CI 0.22 to 4.34, p=0.97).
Comparing pre- and post-pathway implementation, the safety endpoint incidence was 6.7% in both periods (HR 0.70, 95% CI 0.17 to 2.80, p=0.61).
The pathway required patients to be stabilised and meet prespecified criteria before being discharged home for work-up completion and TAVI within 2 weeks.
Background
Up to 30% of patients undergoing TAVI present with acute decompensation of aortic stenosis (acute valve syndrome), and conventional inpatient management is associated with prolonged stays and deconditioning.
Conventional management of AVS patients involves inpatient work-up and treatment by TAVI.
Inpatient management is associated with prolonged hospital stays, deconditioning, and delayed recovery.
This study aimed to evaluate the impact and feasibility of an ultra-rapid outpatient pathway as an alternative approach for selected, stabilised AVS patients.
What This Means
This research suggests that some patients who are hospitalised with a dangerous worsening of severe aortic stenosis (a heart valve problem called 'acute valve syndrome') can be safely sent home sooner and return as outpatients for their valve replacement procedure (called TAVI), rather than staying in hospital throughout their entire treatment. In this single-centre study, about half of eligible patients (55%) met criteria to be discharged home and complete their pre-procedure tests as outpatients, with TAVI performed within two weeks. These outpatients spent a median of 12 days total in hospital, compared to 20 days for those managed the traditional inpatient way — saving an estimated 210 hospital bed-days overall.
Importantly, the faster discharge did not appear to make patients less safe. The rate of serious events (death or emergency re-admission before the valve procedure) was similarly low in both groups — around 6–7% — and was unchanged compared to the period before the new pathway was introduced. The time from referral to actually receiving the valve procedure was also similar between groups, meaning outpatients did not wait any longer for treatment.
This research suggests that for carefully selected and stabilised patients with acute valve syndrome, an ultra-rapid outpatient TAVI pathway is both feasible and appears safe, while meaningfully reducing the time patients spend in hospital. Shorter hospital stays can help patients avoid the physical decline that comes from prolonged bed rest, and can free up hospital resources. The authors note that further research with larger patient numbers is needed to fully validate this approach.
Vibhishanan J, Winn K, Ferreira-Martins J, Sharma H, Hosin A, Konstanciak K, et al.. (2026). Ultra-rapid outpatient treatment of patients with severe aortic stenosis presenting with acute valve syndrome: evaluation of a novel pathway for urgent TAVI.. Open heart. https://doi.org/10.1136/openhrt-2026-004222